Check Brain Temp Trial

NCT04612101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-11-02

No results posted yet for this study

Summary

Despite some controversial results, many patients and animal studies have suggested significant benefit of using hypothermia treatment in stroke patient population. However, certain questions for how to applying this therapy properly such as when to start, what is the optimal temperature, how long is the duration, and what is the best hypothermia technology that may avoid the complications including focal soft tissue injuries are still remain questioned.

In this study, we will utilize the linear relationship of temperature vs. chemical shift in MR Spectroscopy to measure the brain temperatures in normal men.

Conditions

  • the Focus of the Clinical Trial is on the Brain Temperatures in Normal Human Subjects

Sponsors & Collaborators

  • University of Illinois College of Medicine at Peoria

    collaborator OTHER
  • OSF Healthcare System

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612101 on ClinicalTrials.gov